Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drews

Showing results (261-270 of 307) with videos related to

Pageof 31
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 28, 2016
Effectiveness of pertussis vaccination and duration of immunityKevin L Schwartz, Jeffrey C Kwong, Shelley L Deeks, et al.
The Journal of Infectious Diseases|September 22, 2017
Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, CanadaDanuta M Skowronski, Catharine Chambers, Gaston De Serres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2020
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017Danuta M Skowronski, Macy Zou, Quinten Clarke, et al.
Vaccine|April 11, 2019
Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015Natasha S Crowcroft, Kevin L Schwartz, Cynthia Chen, et al.
The Journal of Hospital Infection|January 20, 2020
Sources of viral respiratory infections in Canadian acute care hospital healthcare personnelS Buckrell, B L Coleman, S A McNeil, et al.
Microbiology Spectrum|September 20, 2022
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 VirusesYi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
Vox Sanguinis|August 31, 2021
Babesia microti in a Canadian blood donor and lookback in a red blood cell recipientSteven J Drews, Paul Van Caeseele, Jared Bullard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing IntervalBrian Grunau, Michael Asamoah-Boaheng, Pascal M Lavoie, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 23, 2021
Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006-2008: a Canadian Immunization Research Network studyStephanie L Hughes, Jeffrey C Kwong, Kevin L Schwartz, et al.
Clinical Microbiology Reviews|December 14, 2018
Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract InfectionsCarmen L Charlton, Esther Babady, Christine C Ginocchio, et al.
Pageof 31

Showing results (261-270 of 307) with videos related to

Sort By:
Pageof 31
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 28, 2016
Effectiveness of pertussis vaccination and duration of immunityKevin L Schwartz, Jeffrey C Kwong, Shelley L Deeks, et al.
The Journal of Infectious Diseases|September 22, 2017
Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, CanadaDanuta M Skowronski, Catharine Chambers, Gaston De Serres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2020
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017Danuta M Skowronski, Macy Zou, Quinten Clarke, et al.
Vaccine|April 11, 2019
Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015Natasha S Crowcroft, Kevin L Schwartz, Cynthia Chen, et al.
The Journal of Hospital Infection|January 20, 2020
Sources of viral respiratory infections in Canadian acute care hospital healthcare personnelS Buckrell, B L Coleman, S A McNeil, et al.
Microbiology Spectrum|September 20, 2022
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 VirusesYi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
Vox Sanguinis|August 31, 2021
Babesia microti in a Canadian blood donor and lookback in a red blood cell recipientSteven J Drews, Paul Van Caeseele, Jared Bullard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing IntervalBrian Grunau, Michael Asamoah-Boaheng, Pascal M Lavoie, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 23, 2021
Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006-2008: a Canadian Immunization Research Network studyStephanie L Hughes, Jeffrey C Kwong, Kevin L Schwartz, et al.
Clinical Microbiology Reviews|December 14, 2018
Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract InfectionsCarmen L Charlton, Esther Babady, Christine C Ginocchio, et al.
Pageof 31